The Geographical Distribution of Leadership in Globalized Clinical Trials

por Hoekman, Jarno, Frenken, Koen, de Zeeuw, Dick, Heerspink, Hiddo Lambers
Publicado 2012

The Use of Surrogate Endpoints in Regulating Medicines for Cardio-Renal Disease: Opinions of Stakeholders

por Schievink, Bauke, Lambers Heerspink, Hiddo, Leufkens, Hubert, De Zeeuw, Dick, Hoekman, Jarno
Publicado 2014

FDA Facilitated Regulatory Pathways: Visualizing Their Characteristics, Development, and Authorization Timelines

por Liberti, Lawrence, Bujar, Magda, Breckenridge, Alasdair, Hoekman, Jarno, McAuslane, Neil, Stolk, Pieter, Leufkens, Hubert
Publicado 2017

The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study

por Jacobs, Tom G., Hilda Ampadu, H., Hoekman, Jarno, Dodoo, Alexander N. O., Mantel-Teeuwisse, Aukje K.
Publicado 2018

Organizational capacities of national pharmacovigilance centres in Africa: assessment of resource elements associated with successful and unsuccessful pharmacovigilance experiences

por Hilda Ampadu, H., Hoekman, Jarno, Arhinful, Daniel, Amoama-Dapaah, Marilyn, Leufkens, Hubert G. M., Dodoo, Alex N. O.
Publicado 2018

Regulatory Safety Learning Driven by the Mechanism of Action: The Case of TNF‐α Inhibitors

por Minnema, Lotte A., Giezen, Thijs J., Hoekman, Jarno, Egberts, Toine C.G., Leufkens, Hubert G.M., Gardarsdottir, Helga
Publicado 2020

Challenges in Advanced Therapy Medicinal Product Development: A Survey among Companies in Europe

por ten Ham, Renske M.T., Hoekman, Jarno, Hövels, Anke M., Broekmans, Andre W., Leufkens, Hubert G.M., Klungel, Olaf H.
Publicado 2018

An analysis of marketing authorisation applications via the mutual recognition and decentralised procedures in Europe

por Ebbers, Hans C., Langedijk, Joris, Bouvy, Jacoline C., Hoekman, Jarno, Boon, Wouter P. C., de Jong, Jean Philippe, De Bruin, Marie L.
Publicado 2015

Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Report...

por Ampadu, Haggar H., Hoekman, Jarno, de Bruin, Marieke L., Pal, Shanthi N., Olsson, Sten, Sartori, Daniele, Leufkens, Hubert G. M., Dodoo, Alexander N. O.
Publicado 2016

Pre‐approval and post‐approval availability of evidence and clinical benefit of conditionally approved cancer drugs in Europe: A comparison with standard approved cancer drugs

por Bloem, Lourens T., Bot, Rosa E., Mantel‐Teeuwisse, Aukje K., van der Elst, Menno E., Sonke, Gabe S., Klungel, Olaf H., Leufkens, Hubert G. M., Hoekman, Jarno
Publicado 2022

The Role of Regulator-Imposed Post-Approval Studies in Health Technology Assessments for Conditionally Approved Drugs

por Vreman, Rick A., Bloem, Lourens T., van Oirschot, Stijn, Hoekman, Jarno, van der Elst, Menno E., Leufkens, Hubert GM, Klungel, Olaf H., Goettsch, Wim G., Mantel-Teeuwisse, Aukje K.
Publicado 2020

Associations between uncertainties identified by the European Medicines Agency and national decision making on reimbursement by HTA agencies

por Bloem, Lourens T., Vreman, Rick A., Peeters, Niels W. L., Hoekman, Jarno, van der Elst, Menno E., Leufkens, Hubert G. M., Klungel, Olaf H., Goettsch, Wim G., Mantel‐Teeuwisse, Aukje K.
Publicado 2021